Integrated Advisors Network’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$431K Buy
2,820
+782
+38% +$120K 0.02% 487
2025
Q4
$281K Sell
2,038
-634
-24% -$83K 0.01% 622
2025
Q3
$343K Buy
2,672
+1,009
+61% +$123K 0.01% 593
2025
Q2
$201K Buy
+1,663
New +$187K 0.01% 720
2024
Q4
Sell
-2,349
Closed -$270K 741
2024
Q3
$270K Buy
+2,349
New +$267K 0.01% 628
2020
Q3
Sell
-3,807
Closed -$332K 475
2020
Q2
$332K Sell
3,807
-23,722
-86% -$2.05M 0.04% 328
2020
Q1
$2.27M Buy
27,529
+1,196
+5% +$107K 0.44% 62
2019
Q4
$2.49M Buy
+26,333
New +$2.36M 0.34% 87

Other funds holding NVS

Integrated Advisors Network's NVS Position: Q1 2026 in Review

Integrated Advisors Network increased its Novartis (NVS) stake by 38% in Q1 2026, buying an estimated $120K and bringing the position to 2,820 shares worth $431K. The position accounts for 0.02% of the portfolio, ranked #487.

Integrated Advisors Network first reported a position in NVS in Q4 2019 and has held it in 8 quarters since. The position peaked at $2.49M in Q4 2019. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Integrated Advisors Network held 2,820 shares of Novartis worth $431K as of Q1 2026.
  • Integrated Advisors Network bought 782 Novartis shares in Q1 2026, an estimated $120K.
  • Novartis made up 0.02% of Integrated Advisors Network's portfolio in Q1 2026, its #487 holding.
  • Integrated Advisors Network first reported a position in Novartis in Q4 2019 and has held it in 8 quarters since.
  • Integrated Advisors Network's Novartis position peaked at $2.49M in Q4 2019.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Integrated Advisors Network's 13F filing for Q1 2026, filed 28 Apr 2026.